244 related articles for article (PubMed ID: 9751927)
1. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
[TBL] [Abstract][Full Text] [Related]
2. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
3. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.
Hoefnagel CA
Eur J Nucl Med; 1994 Jun; 21(6):561-81. PubMed ID: 7915987
[TBL] [Abstract][Full Text] [Related]
4. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region.
van Gils AP; van der Mey AG; Hoogma RP; Falke TH; Moolenaar AJ; Pauwels EK; van Kroonenburgh MJ
J Nucl Med; 1990 Jul; 31(7):1147-55. PubMed ID: 2163439
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
7. MIBG and radiolabeled octreotide in neuroendocrine tumors.
Hoefnagel CA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
[TBL] [Abstract][Full Text] [Related]
8. Meta-[123I]iodobenzylguanidine single photon emission computed tomography in chemodectomas.
Virotta G; Medolago G; Zappone C; Moschini L; Torre L; Mazzoni A; Bertocchi C
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):9-12. PubMed ID: 9002741
[TBL] [Abstract][Full Text] [Related]
9. Multiple chemodectomas. Carotid body tumor masked by salivary gland uptake on I-123 MIBG scintigraphy.
Weissman AF; Gonzalez CE; Shapiro B; Shulkin B; Francis IR; Leach K
Clin Nucl Med; 1994 Jun; 19(6):527-31. PubMed ID: 8062474
[TBL] [Abstract][Full Text] [Related]
10. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
[TBL] [Abstract][Full Text] [Related]
12. The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
Kaltsas GA; Mukherjee JJ; Grossman AB
Ann Oncol; 2001; 12 Suppl 2():S47-50. PubMed ID: 11762352
[TBL] [Abstract][Full Text] [Related]
13. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy.
van Gelder T; Verhoeven GT; de Jong P; Oei HY; Krenning EP; Vuzevski VD; van den Meiracker AH
J Nucl Med; 1995 Apr; 36(4):620-2. PubMed ID: 7699455
[TBL] [Abstract][Full Text] [Related]
15. Synchronous ileocecal neuroendocrine tumor and carotid chemodectoma: diagnosis by 111In pentetreotide SPECT/CT.
Wisotzki C; Jacobsen F; Salamon J; Derlin T
Clin Nucl Med; 2014 Jun; 39(6):547-8. PubMed ID: 24097001
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
17. Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases.
Duet M; Herman P; Wassef M; Tran BH; Laredo JD
J Magn Reson Imaging; 2006 Aug; 24(2):428-33. PubMed ID: 16786569
[TBL] [Abstract][Full Text] [Related]
18. The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
Shi W; Buchanan KD; Johnston CF; Larkin C; Ong YL; Ferguson R; Laird J
Clin Endocrinol (Oxf); 1998 Mar; 48(3):303-9. PubMed ID: 9578820
[TBL] [Abstract][Full Text] [Related]
19. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
20. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.
Kopf D; Bockisch A; Steinert H; Hahn K; Beyer J; Neumann HP; Hensen J; Lehnert H
Clin Endocrinol (Oxf); 1997 Jan; 46(1):39-44. PubMed ID: 9059556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
